U.S. Rep. Larry Bucshon (R-Ind.), vice chair of the House Energy & Commerce health subcommittee, has written a bill to impose significant 340B program reporting requirements on disproportionate share hospitals and potentially other covered entities. Meanwhile, two bills have been
…
U.S. Health Resources and Services Administration Administrator Carole Johnson said on Capitol Hill yesterday that HRSA would welcome congressional help ensuring there is “accountability and transparency” in the 340B program.
Johnson was answering questions from Rep. Morgan Griffith (R-Va.) during
…
With just weeks to go in its legislative session, Missouri lawmakers are making progress on two different 340B anti-discrimination bills. Last week, a key Senate committee approved SB 26, comprehensive legislation with two key priorities: prohibiting drug manufacturers from placing
…
A California Senate health committee yesterday unanimously approved a bill to prohibit pharmacy benefit managers from employing practices that 340B covered entities view as discriminatory. On Wednesday, California’s SB-786 was approved by the Senate Health Committee and now goes
…
About a dozen people who advise, help run, or work at 340B covered entities are launching a nonprofit group, 340B Truth, to try to hammer out a covered entity consensus position on 340B reform and urge Congress to pass it
…
A hearing is set for Thursday in the Louisiana House on a bill to stop drug manufacturers from impeding 340B covered entities’ use of contract pharmacies.
State Rep. Chris Turner (R) introduced House Bill 548, the Defending Affordable Prescription
…
The New York legislature on Monday passed a short-term state funding bill with $9 million in supplemental aid for Ryan White clinics that are losing 340B revenue due to the April 1 transfer of the state’s Medicaid managed care drug
…
New Mexico Gov. Michelle Lujan Grisham (D) signed a law April 7 to prevent pharmacy benefit managers and insurers from discriminating against 340B providers. The bill includes language that prohibits payers from reimbursing 340B covered entities at a lower rate
…
U.S. Senate Health, Education, Labor, and Pensions Committee staff members reportedly have decided to exclude 340B issues from a bipartisan drug policy bill they are writing behind the scenes in order to preserve the bill’s odds of being passed next
…
×
*Sign up for news summaries and alerts from 340B Report